References with Clinical Peptides
Publications
- Peptide Pools For Target Antigen Identification, Immune Monitoring, and Cellular Therapy
- Autologous Adoptive T-Cell Therapy for Recurrent or Drug-Resistant Cytomegalovirus Complications in Solid Organ Transplant Patients: A Single-Arm Open-Label Phase I Clinical Trial
- Human Parainfluenza Virus-3 Can be Targeted by Rapidly Ex Vivo Expanded T Lymphocytes
- Peptide‐Stimulated Expansion of Virus‐Specific T Cells for Preventative Treatment After Allogeneic Stem Cell Transplantation
- Broadly-Specific Cytotoxic T Cells Targeting Multiple HIV Antigens Are Expanded From HIV+ Patients: Implications for Immunotherapy
- Expanded Cytotoxic T-Cell Lymphocytes Target the Latent HIV Reservoir
- Ex vivo Expansion of Human T cells for Adoptive Immunotherapy Using the Novel Xeno-free CTS Immune Cell Serum Replacement
- PepMixes to Generate Multiviral CTLS with Broad Specificity
- Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma
Archive
- QIMR Berghofer Medical Research Institute Selects JPT’s GxP PepMix™ Peptide Pool Technology to Support its Phase I/II Clinical Trials of Adoptive Immunotherapy for Human Cytomegalovirus-associated Diseases
- Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections After HSCT
- Immunotherapeutic Strategies to Prevent and Treat Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation
- Rapidly Generated Multivirus-specific Cytotoxic T lymphocytes for the Prophylaxis and Treatment of Viral Infections
- LMP-Specific T-Cells for Patients With Relapsed EBV-Positive Lymphoma (ALCI)
- Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
- Cytotoxic T Lymphocyte Therapy with Donor T Cells Prevents and Treats Adenovirus and Epstein-Barr Virus Infections after Haploidentical and Matched Unrelated Stem Cell Transplantation
All Our Publications
- References with PepMaster™
- References with PepMix™ Peptide Pools - Control Pools
- References with PepMix™ Peptide Pools - Infectious Diseases
- References with PepMix™ Peptide Pools - Tumor Associated Antigens
- References with Clinical Peptides
- References with PepStar™ & RepliTope™ Peptide Microarrays
- References with Peptide ELISA
- References with Reference Peptides for Targeted Proteomics - SpikeTides™ & SpikeMix™
- References with Absolute Quantified Peptides - SpikeTides™ TQL & SpikeTides™ TQL PLUS
- References with PepTrack™ Peptide Libraries
- References with Custom Peptide Synthesis
- References with Specialty Peptides
- References with Conjugates
- References with SpotMix™
- References with PepSpots™ Peptides on Cellulose
- References with Amyloid Beta Peptides
- References with Antigen Peptides
- References with Micro-Scale Peptide Sets
- References with BioTides™ Biotinylated Peptides
- References with ProteaseSpots™
- References with Histone Code Tools
- References with Enzyme Substrate Microarrays
- References with Enzyme Profiling - Assay Service
- References with Enzyme Substrate Sets
- References with Protein Interaction Screen on Peptide Matrix (PRISMA)
- References with Microarray Accessories
- References with Bioinformatics: Library Design, Data Mining & Evaluation
- References with Computational Chemistry: Molecular Design and Lead Optimization
- References with MHC Multimers